EZElisa™固醇调节元件结合蛋白1C（SREBP-1C）
ELISA试剂盒-EZElisa™ Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit- 询价
- Biogradetech
- 美国
- A-QEK06081-96wells
- 2025年12月16日
企业认证
相关产品推荐更多 >
EZElisa™大鼠基质金属蛋白酶14（MMP 14）ELISA试剂盒-EZElisa™ Rat Matrix Metalloproteinase 14 (MMP14) ELISA Kit
询价
EZElisa™尿苷三磷酸（UTP）试剂盒-EZElisa™ Uridine Triphosphate (UTP) Kit
询价
EZElisa™小鼠突触蛋白II（SYN2）ELISA试剂盒-EZElisa™ Mouse Synapsin II (SYN2) ELISA Kit
询价EZElisa™大鼠基质金属蛋白酶1（MMP 1）ELISA试剂盒-EZElisa™ Rat Matrix Metalloproteinase 1 (MMP1) ELISA Kit
询价
EZElisa ™ Tuftelin（TUFT 1）ELISA试剂盒-EZElisa™ Tuftelin (TUFT1) ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™固醇调节元件结合蛋白1C（SREBP-1C）ELISA试剂盒，EZElisa™ Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit，固醇调节元件结合蛋白1C（SREBP-1C）ELISA试剂盒, Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit
产品名称：EZElisa™固醇调节元件结合蛋白1（SREBF 1）ELISA试剂盒-EZElisa™ Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit
产品货号：A-QEK06081-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：
该EZElisa™固醇调节元件结合蛋白1C（SREBP-1C）ELISA试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™固醇调节元件结合蛋白1（SREBF 1）ELISA试剂盒-EZElisa™ Sterol Regulatory element-Binding Protein 1C(SREBP-1C) ELISA Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验HIV-1 Chromatin, Transcription, and the Regulatory Protein Tat
by recruiting the cellular positive transcription elongation factor p-TEFb to the TAR element located at the 5′ end of all nascent viral transcripts, thereby promoting efficient elongation. This chapter describes two complementary techniques for analyzing
Assuring the Quality of Vaccines: Regulatory Requirements for Licensing and Batch Release
Ensuring the consistent safety and efficacy of a vaccine has long been recognized as an essential element in a successful disease-control program. Indeed, the development of appropriate laboratory methods to characterize a vaccine
Assuring the Quality and Safety of Vaccines: Regulatory Expectations for Licensing and Batch Release
Ensuring the consistent safety and efficacy of a vaccine has long been recognized as an essential element in a successful disease-control program. Indeed, the development of appropriate laboratory methods to characterize a vaccine
技术资料暂无技术资料 索取技术资料
